{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:09:04Z","timestamp":1760954944603},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.autrev.2007.02.014","type":"journal-article","created":{"date-parts":[[2007,3,23]],"date-time":"2007-03-23T10:49:18Z","timestamp":1174646958000},"page":"127-131","source":"Crossref","is-referenced-by-count":39,"title":["From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity"],"prefix":"10.1016","volume":"7","author":[{"given":"Paolo","family":"Ghia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Scielzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Frenquelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Muzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Caligaris-Cappio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2007.02.014_bib1","first-page":"574","article-title":"CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity","volume":"48","author":"Youinou","year":"2000","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.autrev.2007.02.014_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.3105056","article-title":"Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset","volume":"236","author":"Casali","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.autrev.2007.02.014_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0167-5699(91)90135-G","article-title":"A new nomenclature for B cells","volume":"12","author":"Kantor","year":"1991","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2007.02.014_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni1301","article-title":"Identification of a B-1 B cell-specified progenitor","volume":"7","author":"Montecino-Rodriguez","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2007.02.014_bib5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.iy.11.040193.002441","article-title":"Origin of murine B cell lineages","volume":"11","author":"Kantor","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2007.02.014_bib6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/eji.1830161021","article-title":"Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage","volume":"16","author":"Hayakawa","year":"1986","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2007.02.014_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.autrev.2005.10.007","article-title":"Role of B-1a cells in autoimmunity","volume":"5","author":"Duan","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2007.02.014_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0167-5699(95)80047-6","article-title":"Involvement of B-1 cells in mucosal immunity and autoimmunity","volume":"16","author":"Murakami","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2007.02.014_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2141.1983.tb02114.x","article-title":"Normal equivalent cells of B cell malignancies: analysis with monoclonal antibodies","volume":"54","author":"Gobbi","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2007.02.014_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1749-6632.1997.tb52059.x","article-title":"Natural autoantibodies, tolerance, and autoimmunity","volume":"815","author":"Dighiero","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2007.02.014_bib11","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1073\/pnas.92.8.3348","article-title":"B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes","volume":"92","author":"Wortis","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2007.02.014_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/intimm\/5.8.809","article-title":"Induction of CD5 antigen on human CD5-B cells by stimulation with Staphylococcus aureus Cowan strain I","volume":"5","author":"Morikawa","year":"1993","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2007.02.014_bib13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.V73.5.1259.1259","article-title":"Human normal CD5+ B lymphocytes can be induced to differentiate to CD5-B lymphocytes with germinal center cell features","volume":"73","author":"Caligaris-Cappio","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib14","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.4049\/jimmunol.140.12.4180","article-title":"Human monoclonal rheumatoid factor-like antibodies from CD5 (Leu-1)+ B cells are polyreactive","volume":"140","author":"Nakamura","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2007.02.014_bib15","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1182\/blood.V99.11.4087","article-title":"B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes","volume":"99","author":"Damle","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jcp.39.7.713","article-title":"Autoimmunity in chronic lymphocytic leukaemia","volume":"39","author":"Hamblin","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2007.02.014_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.hoc.2004.04.002","article-title":"Perspectives in CLL biology and management","volume":"18","author":"Dighiero","year":"2002","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.autrev.2007.02.014_bib18","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood.V81.10.2475.2475","article-title":"Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases","volume":"81","author":"Kipps","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1182\/blood-2005-11-4620","article-title":"Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries","volume":"108","author":"Landgren","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0140-6736(93)91681-B","article-title":"Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia","volume":"342","author":"Leporrier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2007.02.014_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2141.1995.tb05300.x","article-title":"Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia","volume":"91","author":"Myint","year":"1995","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2007.02.014_bib22","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1007\/s00282-997-0041-4","article-title":"Complications in the treatment of CLL with purine analogues","volume":"39","author":"Juliusson","year":"1997","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.autrev.2007.02.014_bib23","first-page":"283","article-title":"An attempt to explain disordered immunity and hypogammaglobulinemia in B-CLL","volume":"30","author":"Dighiero","year":"1988","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.autrev.2007.02.014_bib24","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1182\/blood-2003-12-4312","article-title":"Chronic lymphocytic leukemia: revelations from the B-cell receptor","volume":"103","author":"Stevenson","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","article-title":"B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor","volume":"21","author":"Chiorazzi","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2007.02.014_bib26","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib27","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.coi.2004.01.005","article-title":"The regulation of somatic hypermutation","volume":"16","author":"Besmer","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2007.02.014_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.immunol.23.021704.115732","article-title":"Antigen-specific memory B cell development","volume":"23","author":"McHeyzer-Williams","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2007.02.014_bib30","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2004-07-2606","article-title":"Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene","volume":"105","author":"Ghia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib31","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1172\/JCI19399","article-title":"Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia","volume":"113","author":"Ghiotto","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2007.02.014_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20040544","article-title":"Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia","volume":"200","author":"Messmer","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2007.02.014_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib34","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood-2004-01-0132","article-title":"Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia","volume":"104","author":"Tobin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib35","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood.V99.6.2262","article-title":"Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia","volume":"99","author":"Tobin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib36","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1182\/blood-2004-03-0818","article-title":"Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins","volume":"104","author":"Widhopf","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib37","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI24387","article-title":"Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity","volume":"115","author":"Herve","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2007.02.014_bib38","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","article-title":"Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia","volume":"101","author":"Lanham","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2007.02.014_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1084\/jem.178.1.331","article-title":"The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A","volume":"178","author":"Hillson","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2007.02.014_bib40","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood-2006-08-044008","article-title":"Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia","volume":"109","author":"Landgren","year":"2007","journal-title":"Blood"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997207000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997207000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T04:43:44Z","timestamp":1683780224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997207000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1568997207000638"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2007.02.014","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}